UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Koninklijke Philips N.V. |
||||
(Translation of registrants name into English) | ||||
The Netherlands | ||||
(Jurisdiction of incorporation or organization) | ||||
Breitner Center, Amstelplein 2, 1096 BC Amsterdam, The Netherlands | ||||
(Address of principal executive office) |
||||
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F: [x] Form 20-F [ ] Form 40-F | ||||
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): [ ] | ||||
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): [ ] | ||||
Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934: [ ] Yes [x] No | ||||
If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): n/a |
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. |
Koninklijke Philips N.V. | ||
Date: 11/04/2016 | By: |
/s/ M.J. van Ginneken |
Name: | M.J. van Ginneken | |
Title: | General Secretary | |
Exhibit No. | Description | |
|
|
|
99 | Press release: Philips provides company update on HealthTech strategy and performance roadmap at Capital Markets Day | |
Press Information
November 4, 2016
Philips provides company update on HealthTech strategy and performance roadmap at Capital Markets Day
Philips has transformed into a global HealthTech leader focused on capturing opportunities
in attractive growth markets
Company targets mid-single-digit comparable sales growth [1] (4% 6%) and Adjusted EBITA [2]
margin step-up of 100 basis points on average per year for the medium term [3]
ROIC associated with organic growth plan to improve to mid-to-high teens
Annual cash generation of approximately EUR 1 billion EUR 1.5 billion
London, UK At a meeting with investors and financial analysts today in London, Royal Philips (NYSE: PHG, AEX: PHIA) will provide the financial markets with an update on the companys transformation into a global HealthTech leader and the performance roadmap. At the meeting, Philips Chief Executive Officer Frans van Houten, Chief Financial Officer Abhijit Bhattacharya and other senior managers will discuss the companys strategy to continue on its path to capture the many attractive opportunities in the growing health technology market.
I am proud that after five years, Philips has transformed into a focused HealthTech leader with a broad portfolio of innovative solutions to drive better health outcomes for people and higher productivity for care providers, said Frans van Houten. The businesses in our HealthTech portfolio are strong and have the right fundamentals for sustained profitable growth. Looking ahead, I am confident in our strategy. We target a performance trajectory to deliver 4-6% comparable sales growth and a 100 basis point improvement in Adjusted EBITA on average per year for the next three to four years. This will bring us in line with the average market profitability of mid-teens.
Leveraging its innovative healthcare technology, deep clinical expertise, strong consumer franchise and global market reach, Philips will create value for its customers and shareholders by:
Improving margins by serving customers better, driving productivity, while continuing to invest in innovation and the digital transformation.
Boosting growth through deep customer partnerships and expanding global geographic coverage.
Providing innovative solutions with smart suites of systems, devices, software and services
improving patient outcomes and provider productivity.
Next to the mid-single-digit (4% 6%) comparable sales growth and an Adjusted EBITA margin step-up of 100 basis points on average per year for the HealthTech portfolio for the medium term, Philips also expects to improve the Return on Invested Capital (ROIC) to mid-to-high teens based on the organic growth plan, and to generate approximately EUR 1 billion EUR 1.5 billion in cash annually.
Presentations in London will start at 10:00 AM CET. Until around 13:10 PM CET, the plenary sessions can be followed via a live webcast. A video summary of the subsequent business zooms will be made available soon after the end of the event. Please click on this link to follow the webcast and download the slides that will be used during the day.
[1] Comparable sales exclude the effect of currency movements and acquisitions and divestments (changes in consolidation). Philips believes that comparable sales information enhances understanding of sales performance. |
[2] Adjusted EBITA is defined as Income from operations (EBIT) excluding amortization of acquired intangible assets, impairment of goodwill and other intangible assets, restructuring charges, acquisition-related costs and other significant items. |
[3] Medium term is 3-4 years. |
For further information, please contact:
Steve Klink
Philips Group Communications
Tel.: +31 6 10888824
E-mail: steve.klink@philips.com
Vanessa Bruinsma-Kleijkers
Philips Investor Relations
Tel.: +31 20 5977447
Email: Vanessa.Bruinsma-Kleijkers@philips.com
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving
peoples health and enabling better outcomes across the health continuum from healthy living and
prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep
clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands,
the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health
informatics, as well as in consumer health and home care. Philips health technology portfolio
generated 2015 sales of EUR 16.8 billion and employs approximately 70,000 employees with sales and
services in more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
Forward-looking statements
This release may contain certain forward-looking statements with respect to the financial
condition, results of operations and business of Philips and certain of the plans and objectives of
Philips with respect to these items. By their nature, forward-looking statements involve risk and
uncertainty because they relate to events and depend on circumstances that will occur in the future
and there are many factors that could cause actual results and developments to differ materially
from those expressed or implied by these forward-looking statements.
This press release contains inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.